174 related articles for article (PubMed ID: 30292894)
1. Improved oral bioavailability of notoginsenoside R1 with sodium glycocholate-mediated liposomes: Preparation by supercritical fluid technology and evaluation in vitro and in vivo.
Fan Q; Zhang Y; Hou X; Li Z; Zhang K; Shao Q; Feng N
Int J Pharm; 2018 Dec; 552(1-2):360-370. PubMed ID: 30292894
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W
Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880
[TBL] [Abstract][Full Text] [Related]
3. Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.
Yang G; Zhao Y; Zhang Y; Dang B; Liu Y; Feng N
Int J Nanomedicine; 2015; 10():6633-44. PubMed ID: 26543366
[TBL] [Abstract][Full Text] [Related]
4. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation.
Niu M; Lu Y; Hovgaard L; Wu W
Int J Nanomedicine; 2011; 6():1155-66. PubMed ID: 21822379
[TBL] [Abstract][Full Text] [Related]
5. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
6. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug.
Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R
J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915
[TBL] [Abstract][Full Text] [Related]
7. Optimization, cellular uptake, and in vivo evaluation of Eudragit S100-coated bile salt-containing liposomes for oral colonic delivery of 5-aminosalicylic acid.
Alghurabi H; Jassim Muhammad H; Tagami T; Ogawa K; Ozeki T
Int J Pharm; 2023 Dec; 648():123597. PubMed ID: 37952559
[TBL] [Abstract][Full Text] [Related]
8. Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats.
Zhang J; Han X; Li X; Luo Y; Zhao H; Yang M; Ni B; Liao Z
Int J Nanomedicine; 2012; 7():4299-310. PubMed ID: 22915851
[TBL] [Abstract][Full Text] [Related]
9. Improved self-assembled micelles based on supercritical fluid technology as a novel oral delivery system for enhancing germacrone oral bioavailability.
Hou X; Cao B; He Y; Guo T; Li Z; Liu Y; Zhang Y; Feng N
Int J Pharm; 2019 Oct; 569():118586. PubMed ID: 31377407
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.
Anderson KE; Eliot LA; Stevenson BR; Rogers JA
Pharm Res; 2001 Mar; 18(3):316-22. PubMed ID: 11442271
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
Liu Y; Luo X; Xu X; Gao N; Liu X
Int J Pharm; 2017 Jan; 517(1-2):1-7. PubMed ID: 27899320
[TBL] [Abstract][Full Text] [Related]
12. Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model.
Kovvasu SP; Kunamaneni P; Yeung S; Rueda J; Betageri GV
AAPS PharmSciTech; 2019 Jun; 20(6):226. PubMed ID: 31214813
[TBL] [Abstract][Full Text] [Related]
13. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Zhou Y; Ning Q; Yu DN; Li WG; Deng J
J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705
[TBL] [Abstract][Full Text] [Related]
14. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
Han HK; Shin HJ; Ha DH
Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117
[TBL] [Abstract][Full Text] [Related]
15. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
Ghassemi S; Haeri A; Shahhosseini S; Dadashzadeh S
AAPS PharmSciTech; 2018 Oct; 19(7):2961-2970. PubMed ID: 30030724
[TBL] [Abstract][Full Text] [Related]
16. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
17. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
[TBL] [Abstract][Full Text] [Related]
18. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
Zhao M; Lee SH; Song JG; Kim HY; Han HK
Int J Pharm; 2018 Jun; 544(1):14-20. PubMed ID: 29655795
[TBL] [Abstract][Full Text] [Related]
19. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.
Hu S; Niu M; Hu F; Lu Y; Qi J; Yin Z; Wu W
Int J Pharm; 2013 Jan; 441(1-2):693-700. PubMed ID: 23089580
[TBL] [Abstract][Full Text] [Related]
20. Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin.
Cui M; Wu W; Hovgaard L; Lu Y; Chen D; Qi J
Int J Pharm; 2015 Jul; 489(1-2):277-84. PubMed ID: 25957702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
